Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

AICAR (phosphate)

AICAR phosphate (Acadesine phosphate) is an adenosine analog and a AMPK activator. AICAR phosphate regulates the glucose and lipid metabolism, and inhibits proinflammatory cytokines and iNOS production. AICAR phosphate is also an autophagy, YAP and mitophagy inhibitor[1][2].

Product Specifications

CAS Number

[681006-28-0]

Product Name Alternative

Acadesine phosphate; AICA Riboside phosphate

UNSPSC

12352005

Target

AMPK; Autophagy; Endogenous Metabolite; Mitophagy; YAP

Type

Natural Products

Related Pathways

Autophagy; Epigenetics; Metabolic Enzyme/Protease; PI3K/Akt/mTOR; Stem Cell/Wnt

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/AICAR-phosphate.html

Purity

99.98

Solubility

DMSO : 250 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)

Smiles

OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C=NC(C(N)=O)=C2N)O1.O=P(O)(O)O

Molecular Formula

C9H17N4O9P

Molecular Weight

356.23

References & Citations

[1]Nakamaru K, et al. AICAR, an activator of AMP-activated protein kinase, down-regulates the IR expression in HepG2 cells. Biochem Biophys Res Commun. 2005 Mar 11;328 (2) :449-54|[2]Drake JC, et al. AICAR treatment for 14 days normalizes obesity-induced dysregulation of TORC1 signaling and translational capacity in fasted skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2010 Dec;299 (6) :R1546-54.|[3]Pold R, et al. Long-term AICAR administration and exercise prevents diabetes in ZDF rats.Diabetes. 2005 Apr;54 (4) :928-34.|[4]Giri S, et al. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside inhibits proinflammatory response in glial cells: a possible role of AMP-activated protein kinase. J Neurosci. 2004 Jan 14;24 (2) :479-87.|[5]Ajaybabu V Pobbati, et al. A combat with the YAP/TAZ-TEAD oncoproteins for cancer therapy. Theranostics. 2020 Feb 18;10 (8) :3622-3635.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Scientific Category

Natural Products

Clinical Information

Phase 3

Isoform

AMPK; Human Endogenous Metabolite

Citation 01

Am J Chin Med. 2020;48 (7) :1693-1713.|J Cell Mol Med. 2023 Apr;27 (8) :1069-1082.|J Ethnopharmacol. 2023 Dec 5:317:116731.|Research Square Preprint. 2021 Aug.|Research Square Print. December 19th, 2022.|ACS Nano. 2025 Aug 26;19 (33) :30441-30454.|Acta Biochim Biophys Sin (Shanghai) . 2018 Feb 1;50 (2) :144-155.|Acta Biochim Biophys Sin (Shanghai) . 2021 Jan 12;53 (1) :112-118.|Acta Cardiol. 2023 Jul;78 (5) :594-606.|Adipocyte. 2022 Dec;11 (1) :562-571.|Alzheimers Res Ther. 2025 Jun 23;17 (1) :141.|Antioxid Redox Signal. 2024 Jan;40 (1-3) :16-39.|Antiviral Res. 2023 Mar:211:105542.|Antiviral Res. 2025 Jan 16:235:106081.|Aquac Nutr. 2025 Feb 26:2025:9406490.|Aquac Rep. 2023 Jun, 30, 101549.|Aquaculture. 2025 Jan 15.|Arab J Chem. 2024 Aug.|Arch Biochem Biophys. 2023 Aug:744:109689.|Arch Toxicol. 2019 Jun;93 (6) :1697-1712. |Authorea. September 07, 2022.|Biochem Biophys Res Commun. 2023 Oct 1:675:54-60.|Biochem Pharmacol. 2025 Jul 12:241:117162.|Biochim Biophys Acta Mol Basis Dis. 2018 Nov;1864 (11) :3723-3738. |Biochim Biophys Acta Mol Basis Dis. 2022 May 1;1868 (5) :166369.|Biochim Biophys Acta Mol Basis Dis. 2024 Jun 25:167314.|Biochim Biophys Acta Mol Cell Biol Lipids. 2024 Mar;1869 (2) :159428.|Biochim Biophys Acta Mol Cell Res. 2022 Aug;1869 (8) :119265.|Biomed Environ Sci. 2019 Dec;32 (12) :944-948.|Biomed Pharmacother. 2023 Aug:164:114907.|Biomedicines. 2022 Jan 13;10 (1) :165.|bioRxiv. 2021 Jan 31.|bioRxiv. 2024 May 25.|bioRxiv. 2025 Aug 28:2025.08.28.672931.|bioRxiv. 2025 Jul 12:2025.07.08.663754.|bioRxiv. 2025 May 05.|bioRxiv. 2025 Sep 29.|Br J Cancer. 2023 May;128 (9) :1647-1664.|Br J Pharmacol. 2025 May 13.|Cancer Cell. 2020 Sep 14;38 (3) :350-365.e7.|Cancer Lett. 2025 May 23:217810.|Cancer Res. 2023 Dec 15;83 (24) :4063-4079.|Cancer Res. 2025 Mar 14;85 (6) :1113-1129.|Cardiovasc Toxicol. 2024 Sep;24 (9) :889-903.|Cell Biol Int. 2023 Nov;47 (11) :1813-1824.|Cell Biol Int. 2024 Jan;48 (1) :46-59.|Cell Biol Toxicol. 2025 Feb 3;41 (1) :39.|Cell Commun Signal. 2023 May 4;21 (1) :99.|Cell Commun Signal. 2024 Nov 7;22 (1) :534.|Cell Death Differ. 2021 Apr;28 (4) :1222-1236.|Cell Death Differ. 2025 May 22.|Cell Death Dis. 2018 May 1;9 (5) :515.|Cell Death Dis. 2021 May 18;12 (6) :506.|Cell Death Dis. 2024 Sep 30;15 (9) :697.|Cell Death Dis. 2025 Feb 3;16 (1) :66.|Cell Death Discov. 2024 Jan 17;10 (1) :34.|Cell Metab. 2019 Jul 2;30 (1) :157-173.e7|Cell Metab. 2025 Jun 3;37 (6) :1364-1380.e6.|Cell Mol Biol Lett. 2022 Aug 9;27 (1) :66.|Cell Rep. 2021 Sep 21;36 (12) :109739.|Cell Rep. 2022 Aug 16;40 (7) :111204.|Cell Rep. 2022 Nov 22;41 (8) :111707.|Cell Signal. 2023 Jan:101:110502.|Cell Signal. 2024 Jun:118:111125.|Cell Signal. 2025 Nov:135:111985.|Cells. 2022 Aug 30;11 (17) :2706.|Chem Eng J. 2025 Sep 15.|Chin Med. 2025 Jul 7;20 (1) :108.|Clin Sci. 2025 Oct 22;139 (20) :1163-1185.|Clin Transl Med. 2020 Oct;10 (6) :e205.|Clin Transl Med. 2022 Mar;12 (3) :e777.|Commun Biol. 2025 May 30;8 (1) :830.|Connect Tissue Res. 2025 Feb 11:1-14.|Curr Eye Res. 2022 May 25;1-13.|Curr Eye Res. 2025 Jun;50 (6) :600-609.|Curr Issues Mol Biol. 2025 Nov 19;47 (11) :963.|Curr Res Food Sci. 2024 Mar 28:8:100728.|Ecotoxicol Environ Saf. 2024 Jan 15:270:115831.|Endocr J. 2022 Apr 28;69 (4) :385-397.|Environ Pollut. 2023 Feb 7;322:121202.|Enzyme Microb Technol. 2021 Mar:144:109737.|Eur J Pharmacol. 2024 Jun 5:972:176543.|Europace. 2025 Oct 31;27 (11) :euaf288.|Exp Eye Res. 2020 Apr;193:107972.|Exp Eye Res. 2024 Apr:241:109851.|Exp Neurol. 2025 Feb 2:386:115174.|Exp Ther Med. 2022 Jun 1;24 (1) :485.|FASEB J. 2020 Nov;34 (11) :14946-14959.|Food Chem Toxicol. 2023 Nov:181:114089.|Food Chem Toxicol. 2024 Jun 5:114790.|Food Funct. 2020 Apr 1;11 (4) :3073-3083.|Food Res Int. 2025 Aug 29;221:117392.|Free Radic Biol Med. 2023 Feb 1:195:89-102.|Free Radic Biol Med. 2025 Jul:234:248-263.|Front Immunol. 2021 Nov 8:12:753681.|Front Microbiol. 2020 Feb 28;11:320.|Front Pharmacol. 2018 Apr 16:9:345.|Front Pharmacol. 2018 Jul 16:9:761.|Front Pharmacol. 2020 Jul 31;11:1038.|Front Pharmacol. 2021 Jul 7:12:687394.|Front Pharmacol. 2022 May 13;13:887497.|Front Pharmacol. 2023 Apr 18:14:1148611.|Front Pharmacol. 2025 Mar 26:16:1527316.|Front Physiol. 2021 Oct 27:12:745058.|Genes (Basel) . 2022 Dec 16;13 (12) :2384.|Gut Microbes. 2024 Jan-Dec;16 (1) :2412381.|Heliyon. 2023 Nov 28;9 (12) :e22939.|Herald of Medicine. 2023 Jun, 42 (6) : 781-789.|Int Immunopharmacol. 2022 May:106:108600.|Int Immunopharmacol. 2022 Oct:111:109114.|Int Immunopharmacol. 2022 Oct:111:109165.|Int J Biol Macromol. 2023 Aug 30:247:125816.|Int J Biol Macromol. 2024 Feb 5;262 (Pt 1) :129950.|Int J Biol Macromol. 2025 Oct 12;330 (Pt 4) :148291.|Int J Biol Macromol. 2025 Sep;321 (Pt 4) :146448.|Int J Biol Sci. 2021 Jul 22;17 (12) :3091-3103.|Int J Biol Sci. 2024 Aug 19;20 (11) :4476-4495.|Int J Mol Med. 2018 Aug;42 (2) :799-810. |Int J Mol Med. 2018 May;41 (5) :2535-2544.|Int J Mol Med. 2023 Apr;51 (4) :34.|Int J Mol Med. 2025 Feb;55 (2) :26.|Int J Mol Sci. 2025 Feb 11;26 (4) :1521.|iScience. 2023 Jul 12;26 (8) :107295.|J Agric Food Chem. 2019 Jun 26;67 (25) :7060-7072.|J Agric Food Chem. 2021 Aug 11;69 (31) :8714-8725.|J Agric Food Chem. 2022 Sep 14;70 (36) :11324-11335.|J Agric Food Chem. 2024 May 8;72 (18) :10339-10354.|J Agric Food Chem. 2024 Sep 25;72 (38) :21052-21064.|J Anim Sci Biotechnol. 2023 Nov 2;14 (1) :141.|J Biol Chem. 2022 Dec;298 (12) :102587.|J Biol Chem. 2024 Jul 11:107549.|J Cardiovasc Pharmacol. 2022 May 1;79 (5) :730-738.|J Cell Mol Med. 2020 Aug;24 (16) :9135-9144.|J Cell Mol Med. 2022 Feb;26 (3) :893-912.|J Cell Physiol. 2018 Dec;233 (12) :9701-9715.|J Ethnopharmacol. 2024 Jan 30;319 (Pt 1) :117162.|J Exp Clin Cancer Res. 2021 Jun 23;40 (1) :206.|J Funct Foods. 2024 May, 116, 106168.|J Immunol Res. 2022 Feb 8;2022:2619781.|J Immunol. 2022 Dec 1;209 (11) :2181-2191.|J Integr Med. 2022 Jul;20 (4) :365-375.|J Leukoc Biol. 2022 Aug;112 (2) :299-311.|J Nanobiotechnology. 2025 Jul 5;23 (1) :486.|J Oncol. 2021 Jul 14:2021:8281718.|J Orthop Surg Res. 2023 Jun 27;18 (1) :462.|J Photochem Photobiol B. 2020 Dec;213:112075.|J Virol. 2024 Mar 19;98 (3) :e0175123.|JCI Insight. 2022 Mar 8;7 (5) :e154595.|Justus Liebig University Giessen. 2025.|mBio. 2025 Aug 13;16 (8) :e0097625.|Med Oncol. 2023 Dec 26;41 (1) :29.|Mol Biol Rep. 2019 Dec;46 (6) :6435-6451.|Mol Cell Biochem. 2020 Aug;471 (1-2) :91-100.|Mol Cell Endocrinol. 2025 Jan 21:599:112464.|Mol Nutr Food Res. 2024 Jun 11:e2300915.|Nature. 2025 Feb;638 (8052) :1112-1121.|Neural Regen Res. 2026 Jan 1;21 (1) :377-391.|Neurochem Res. 2025 Jun 5;50 (3) :180.|Neuropharmacology. 2024 Nov 1:110206.|NPJ Parkinsons Dis. 2025 May 6;11 (1) :114.|Nutr Res Pract. 2024 Aug;18 (4) :479-497.|Nutrients. 2020 Oct 19;12 (10) :3195.|Nutrients. 2021 May 21;13 (6) :1740.|Oncogene. 2019 Sep;38 (38) :6537-6549.|Oxid Med Cell Longev. 2022 Aug 5:2022:3982613.|Oxid Med Cell Longev. 2022 Oct 4:2022:2353115.|Pharmacol Res. 2021 May:167:105561.|Pharmacol Res. 2022 Jan:175:105985.|Pharmacol Res. 2023 Feb:188:106666.|Phytomedicine. 2021 May:85:153526.|Phytomedicine. 2024 Dec:135:156111.|Phytomedicine. 2024 Jul:129:155534.|Phytother Res. 2019 Jul;33 (7) :1794-1804.|Proc Natl Acad Sci U S A. 2024 Oct 29;121 (44) :e2321305121.|Redox Biol. 2021 Oct:46:102082.|Regen Biomater. 2024 Mar 1:11:rbae020.|Res Sq. 2024 Jun 25.|Res Sq. 2025 Nov 19.|Research Square Preprint. 2021 Sep.|Research Square Preprint. 2023 Jun 26.|Research Square Preprint. 2023 May 26.|Research Square Print. 2022 May.|Research Square Print. 2023 Jan 24.|Sci Rep. 2025 Mar 13;15 (1) :8689.|Signal Transduct Target Ther. 2022 Feb 14;7 (1) :40.|Signal Transduct Target Ther. 2023 Mar 6;8 (1) :95.|Signal Transduct Target Ther. 2025 Sep 26;10 (1) :315.|SSRN. 2024 Sep 28.|SSRN. 2025 May 8.|Stem Cell Res Ther. 2025 Apr 24;16 (1) :206.|Theriogenology. 2024 May 24:225:152-161.|Tissue Cell. 2025 Oct 14:98:103186.|University of Michigan. 2025.|Virus Genes. 2022 Apr;58 (2) :133-142.

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

TIMP1 (Tissue Inhibitor of Metalloproteinases 1, TIMP-1, TIMP, Metalloproteinase Inhibitor 1, Collagenase inhibitor, CLGI, Erythroid-potentiating Activity, EPA, Fibroblast Collagenase Inhibitor) (MaxLight 405) discontinued
143680-ML405 100 µL

TIMP1 (Tissue Inhibitor of Metalloproteinases 1, TIMP-1, TIMP, Metalloproteinase Inhibitor 1, Collagenase inhibitor, CLGI, Erythroid-potentiating Activity, EPA, Fibroblast Collagenase Inhibitor) (MaxLight 405) discontinued

Ask
View Details
2,4,6-Trimethoxybenzaldehyde
291568-01 10 g

2,4,6-Trimethoxybenzaldehyde

Ask
View Details
2,4,6-Trimethoxybenzaldehyde
291568-02 25 g

2,4,6-Trimethoxybenzaldehyde

Ask
View Details
2,4,6-Trimethoxybenzaldehyde
291568-03 50 g

2,4,6-Trimethoxybenzaldehyde

Ask
View Details
2,4,6-Trimethoxybenzaldehyde
291568-04 100 g

2,4,6-Trimethoxybenzaldehyde

Ask
View Details
2,4,6-Trimethoxybenzaldehyde
291568-05 250 g

2,4,6-Trimethoxybenzaldehyde

Ask
View Details